BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
478 employees · est. 2016 · Cambridge, United States
Orchard Therapeutics - U.S.
Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy.
238 employees · est. 2015 · London, United Kingdom
Orchard Therapeutics - U.S. is the older company (2016 vs 2015).
Side-by-Side Comparison
| Metric | BlueRock Therapeutics | Orchard Therapeutics - U.S. |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2015 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | London, United Kingdom |
| Employees | ||
| Employees | 478 | 238 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Acquired | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $1.23B | $485.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 6 |
| Services | ||
| Services | Development of Cell Therapies, Clinical Trial Management, Research and Development | Development of HSC Gene Therapy, Research and Application of Gene Therapy in Genetic Diseases, Patient-centric Therapeutic Solutions |
| Target Customers | ||
| Target Customers | Patients with Degenerative Diseases, Healthcare Providers, Medical Researchers | Families with Members Affected by Genetic Diseases, Healthcare Professionals, Medical Institutions, Researchers in Medical and Genetic Fields |
| Taxonomy | ||
| Taxonomy | Cell Therapy, Clinical Stage Biotech, Neurological Diseases, Ophthalmic Diseases, Parkinson’s Disease, Photoreceptor Diseases, Induced Pluripotent Stem Cells (iPSC), Regenerative Medicine, Heart Muscle Regeneration, Myocardial Infarction Treatment, Chronic Heart Failure, Engineered Cell Therapy, Biopharmaceuticals, Stem Cell Therapeutics, Genome Medicine | Gene Therapy, Hematopoietic Stem Cell Therapy, Autologous Ex Vivo Therapy, Rare Genetic Diseases, Severe Diseases, Strimvelis, Metachromatic Leukodystrophy, Wiskott-Aldrich Syndrome, Adenosine Deaminase Severe Combined Immunodeficiency, X-linked Chronic Granulomatous Disease, Beta-thalassemia, Clinical Research, Commercial-stage Biotech, Partnerships With Academic Institutions, Curative Treatments |
| Website | ||
| Website | bluerocktx.com | orchard-tx.com |
About BlueRock Therapeutics
BlueRock Therapeutics is a cutting-edge, clinical-stage cell therapy company dedicated to reshaping the landscape of disease treatment. Emphasizing the transformative potential of cell therapy, it has constructed a promising pipeline targeting severe neurological and ophthalmic conditions. Key clini...
About Orchard Therapeutics - U.S.
Orchard Therapeutics - U.S., established in 2015, stands as a pioneering force in the Biotechnology and Health Care sectors. As a subsidiary of Kyowa Kirin, it is devoted to transforming lives through innovative gene therapy, particularly targeting severe genetic diseases. Their approach involves th...
We will tell you when either one moves
BounceWatch watches BlueRock Therapeutics and Orchard Therapeutics - U.S. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BlueRock Therapeutics and Orchard Therapeutics -... — by email.
Frequently Asked Questions
Compare BlueRock Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at BlueRock Therapeutics on 9 Jun 2026, and Orchard Therapeutics - U.S. on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
